Company intelligence / Profile preview
McGuff Pharmaceuticals
- Ownership
- Private
- Development stage
- Commercial
Overview
McGuff Pharmaceuticals has achieved FDA approval for several sterile injectable products including ASCOR® (ascorbic acid injection) and hydroxyprogesterone caproate injection. The company operates a state-of-the-art cGMP facility supporting both commercial manufacturing and clinical trial supply. Its 503B outsourcing facility division has developed compounded formulations currently in stability studies but not yet commercially launched[3][6][8].
- Therapeutic areas
- Women's HealthMetabolic Disorders
- Modalities
- Small moleculeBiologicInjectable drug productsCompounded drugs
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on McGuff Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on McGuff Pharmaceuticals.